The evidence of the Welsh study that the live herpes zoster (shingles) vaccine might protect against dementia was interesting but it was using the live vaccine, which is now discontinued in many countries in favor of a recombinant vaccine.
There was a new study last year which showed that the recombinant vaccine is also:
associated with a significantly lower risk of dementia in the 6 years post-vaccination. Specifically, receiving the recombinant vaccine is associated with a 17% increase in diagnosis-free time, translating into 164 additional days lived without a diagnosis of dementia in those subsequently affected.
Here's the report if anyone is interested:
www.nature.com/articles/s41591-024-03201-5.pdf
Should the NHS charge for such things?
Churchill to be axed from British banknotes in the name of diversity.


